Swine Flu - Prevention is Better Than Cure

OXFORD, England, January 10, 2011 /PRNewswire/ --

- With Photo

Only one week into the new year swine flu has already claimed several lives. Healthmap.org believes that swine flu has resulted in hospitalization and even death not only in the UK, but also in other parts of Europe and America. Reports indicate that the virus is even more virulent than last year.

While the Swine Flu (H1N1) virus can be treated with antiviral drugs such as Tamiflu and Relenza which work by preventing the flu virus from reproducing, prevention is better than cure.

The NHS advises people to stay at home if they suspect they have the virus and call the NHS helpline, while the phrase 'catch it, bin it, kill it' reminds people to practice good personal hygiene. Sales of anti-viral hand wash skyrocketed during last year's outbreak and are likely to continue to do so.

One new, innovative way of helping protect yourself is by treating the air you breathe indoors.

Dr Timothy Hadingham, a lead scientist at Atrium Innovation, advises that air-treatment solutions can assist in reducing the bio-burden in the air therefore reducing the quantity of viral particles that people may inhale.

One example of a product which has been proven to reduce the H1N1 swine flu virus and other viruses by 99.99% on contact is Cleanaer - a patented British air purifier. Cleanaer's anti-viral Tea Tree Oil formulation works by suppressing viruses and bacteria in the air and neutralising the viral load of an airborne droplet (like droplets from a sneeze) within 5 minutes of coming into contact with them.

"Cleanaer could help reduce the risk of the spread of harmful germs such as Swine Flu H1N1" says Hadingham.

Scientific evidence from independent sources has verified that Cleanaer can suppress 70% of bacteria from of the air in addition to its other functions which include odour-removal and fragrancing.

Small and compact, Cleanaer is suitable for both healthcare and domestic use.

Visit http://www.cleanaer.com for more information

Contact: +44-(0)1491-838-326, [email protected] - for public and media contact

A picture accompanying this release is available through the PA Photowire. It can be downloaded from http://www.pa-mediapoint.press.net or viewed at http://www.mediapoint.press.net or http://www.prnewswire.co.uk.

SOURCE Atrium Innovation Ltd

Suggested Articles

In an era of limited access to key decision makers, how are you mobilizing your field force to communicate the value of your brands and real-world evidence?

Novo Nordisk’s Ozempic is off to a blazing start, and the company just threw more fuel on the fire with a pair of trial wins.

Biosims to Roche's Big 3 cancer drugs will chisel out a $10 billion sales gap by 2023, but newer meds could chip in $16.3 billion, the drugmaker says.